These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6678865

  • 1. Phase I clinical trial of a new anthracycline: 4'-o-tetrahydropyranyl adriamycin.
    Ogawa M, Miyamoto H, Inigaki J, Horikoshi N, Ezaki K, Inoue K, Ikeda K, Usui N, Nakada H.
    Invest New Drugs; 1983; 1(2):169-72. PubMed ID: 6678865
    [Abstract] [Full Text] [Related]

  • 2. [A phase I trial of 4'-epiadriamycin].
    Ogawa M, Ikeda K, Inagaki J, Horikoshi N, Inoue K, Nakada K, Usui N, Okada Y, Adachi K, Tada A.
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
    [Abstract] [Full Text] [Related]

  • 3. [Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study].
    Wakui A, Yokoyama M, Konno K, Nakai Y, Sakano T, Koyama Y, Imamura Y, Nakajima O, Niijima T, Akaza H.
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):118-24. PubMed ID: 3966806
    [Abstract] [Full Text] [Related]

  • 4. A phase of I trial of 4'-epi-Adriamycin.
    Schauer PK, Wittes RE, Gralla RJ, Casper ES, Young CW.
    Cancer Clin Trials; 1981 Jan; 4(4):433-7. PubMed ID: 7318126
    [Abstract] [Full Text] [Related]

  • 5. [A phase I study of 4'-epi-adriamycin, a new anthracycline anticancer agent].
    Kimura K, Wakui A, Saito T, Tominaga T, Niitani H, Fujimoto T, Masaoka T, Toki H, Tamura K.
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2414-9. PubMed ID: 6594078
    [Abstract] [Full Text] [Related]

  • 6. Phase I trial of 4'-deoxydoxorubicin given weekly.
    Sessa C, Bosia L, Kaplan S, Pusterla C, Varini M, Cavalli F.
    Invest New Drugs; 1984 Nov; 2(4):369-73. PubMed ID: 6511241
    [Abstract] [Full Text] [Related]

  • 7. 1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
    Lokich JJ, Skarin AT, Frei E.
    Cancer; 1974 Nov; 34(5):1593-7. PubMed ID: 4426026
    [No Abstract] [Full Text] [Related]

  • 8. Phase I trial with 4'-deoxydoxorubicin (esorubicin).
    Rozencweig M, Crespeigne N, Kenis Y.
    Invest New Drugs; 1983 Nov; 1(4):309-13. PubMed ID: 6678877
    [Abstract] [Full Text] [Related]

  • 9. 4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors.
    Schütte J, Niederle N, Grunenberg B, Krischke W, Seeber S, Schmidt CG.
    J Cancer Res Clin Oncol; 1984 Nov; 107(1):38-41. PubMed ID: 6583205
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC).
    Chauvergne J, Fumoleau P, Cappelaere P, Metz R, Armand JP, Chevallier B, Kerbrat P, de Forni M, Lhommé C, Roche H.
    Eur J Cancer; 1993 Nov; 29A(3):350-4. PubMed ID: 8398333
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)].
    Nakada H, Ogawa M, Miyamoto H, Inagaki J, Horikoshi N, Inoue K, Ikeda K, Usui N, Adachi K, Okada Y.
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):138-42. PubMed ID: 6696455
    [Abstract] [Full Text] [Related]

  • 17. 4'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study.
    Samonigg H, Kasparek AK, Stöger H, Schmid M, Eber B, Stark G, Weinrauch V, Pfeiffer K, Smola M, Steindorfer P.
    Cancer Chemother Pharmacol; 1990 Jan; 26(4):293-6. PubMed ID: 2369794
    [Abstract] [Full Text] [Related]

  • 18. Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes).
    Cowens JW, Creaven PJ, Greco WR, Brenner DE, Tung Y, Ostro M, Pilkiewicz F, Ginsberg R, Petrelli N.
    Cancer Res; 1993 Jun 15; 53(12):2796-802. PubMed ID: 8504422
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin.
    Miller AA, Schmidt CG.
    Cancer Res; 1987 Mar 01; 47(5):1461-5. PubMed ID: 3815348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.